About Owp Pharmaceuticals
Owp Pharmaceuticals is a private company based in Lisle, Illinois. It has reported $5,135,773 raised in two offerings on Form D since September 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 25, 2025 | Sep 9, 2025 | $2,405,000fully sold | 19 | $126K | EquityRule 506(b) | Form D ↗ |
| Jun 5, 2024 | Sep 16, 2024 | $2,730,773fully sold | 11 | $248K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $5,135,773 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Owp Pharmaceuticals's Form D filed Sep 9, 2025.
TH
Troy Hammond
Director
SB
Steve Bourne
CFO
ML
Matt Litfin
Director
KF
Kurt Florian
Director
SB
Scott Boyer
Executive officer and director
BD
Bruce Duncan
Director
Earlier filings also listed Paul Regan (director, last listed Sep 2024) and Carol Gavin (director, last listed Sep 2024).